Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study.
Tomoko HamayaShingo HatakeyamaToshikazu TanakaYuka KubotaKyo TogashiShogo HosogoeNaoki FujitaAyumu KusakaNoriko TokuiTeppei OkamotoHayato YamamotoTohru YoneyamaTakahiro YoneyamaYasuhiro HashimotoChikara OhyamaPublished in: BJU international (2021)
The use of NAC for high-risk UTUC increased significantly after 2010. Platinum-based short-term NAC followed by immediate RNU may not impede and potentially improves oncological outcomes.